Virginia Retirement Systems Et Al Immunity Bio, Inc. Transaction History

Virginia Retirement Systems Et Al

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 May 17, 2023	SELL	$4.35 - $6.77 $13,484 - $20,987	-3,100 Reduced 21.99%	11,000 $55.8 Million
Q3 2022 May 16, 2023	SELL	$3.65 - $6.43 $28,105 - $49,511	-7,700 Reduced 35.32%	14,100 $70.1 Million
Q1 2022 Apr 21, 2022	BUY	$5.05 - $7.53 $41,915 - $62,499	8,300 Added 61.48%	21,800 $122,000
Q4 2021 Feb 03, 2022	BUY	$5.67 - $10.18 $76,545 - $137,430	13,500 New	13,500 $82,000

204

70M

1.68M

1.31M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.03B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

Stay updated on Virginia Retirement Systems Et Al with notifications on news.